Magnolia Market Access
Magnolia Market Access specializes in market access and HEOR strategies, delivering tailored healthcare product access solutions. As part of the Medical Knowledge Group, it leverages advanced AI, comprehensive HEOR market research, and medical communications to support pharmaceutical and healthcare products from development to market.
Industries
Nr. of Employees
small (1-50)
Magnolia Market Access
200 Crossing Blvd, Suite 7000, Bridgewater Township, NJ 08807
Products
Curated real-world data repository for HEOR and analytics
A curated data repository containing standardized and linkable claims (open and closed), EHR records, social determinants of health data, and Medicare samples for use in HEOR, market access, and commercialization analyses.
Curated real-world data repository for HEOR and analytics
A curated data repository containing standardized and linkable claims (open and closed), EHR records, social determinants of health data, and Medicare samples for use in HEOR, market access, and commercialization analyses.
Services
Monitoring and analysis of policy, development of policy briefs, government engagement support, and reimbursement strategy to support payer coverage and provider reimbursement.
Development of pricing models, contracting strategies, rebate and gross-to-net modeling, payer value propositions, and payer account team training to support pricing and contracting decisions.
End-to-end HEOR planning, study design and execution, non-interventional and observational analyses, economic and outcomes modeling, and scientific dissemination.
Commercial launch planning, distribution strategy, site-of-care analysis, patient journey mapping, competitive landscape assessments, and market geo-mapping using RWD.
Access to a curated data repository for claims, EHR, SDOH, and Medicare samples; BYOD integrations; and management of third-party licensing agreements for analysis.
Recurring webinars, on-demand presentations, and advisory panels on market access, policy changes, RWE methods, and payer strategy.
Monitoring and analysis of policy, development of policy briefs, government engagement support, and reimbursement strategy to support payer coverage and provider reimbursement.
Development of pricing models, contracting strategies, rebate and gross-to-net modeling, payer value propositions, and payer account team training to support pricing and contracting decisions.
End-to-end HEOR planning, study design and execution, non-interventional and observational analyses, economic and outcomes modeling, and scientific dissemination.
Commercial launch planning, distribution strategy, site-of-care analysis, patient journey mapping, competitive landscape assessments, and market geo-mapping using RWD.
Access to a curated data repository for claims, EHR, SDOH, and Medicare samples; BYOD integrations; and management of third-party licensing agreements for analysis.
Recurring webinars, on-demand presentations, and advisory panels on market access, policy changes, RWE methods, and payer strategy.
Expertise Areas
- Market access strategy
- Health economics and outcomes research (HEOR)
- Real-world evidence (RWE) generation
- Payer strategy and pricing
Key Technologies
- Claims data analysis (open and closed)
- Electronic health record (EHR) data linkage
- Social determinants of health (SDOH) analytics
- Tokenization for HIPAA-compliant data linkage
News & Updates
Explore how tariffs and pricing policies could impact pharma pricing, access, and distribution.
Join our free monthly educational series on market access.
A case study on how RWE was used to calculate the national incidence of a rare disease.
Analysis of the new MFN policy signed by President Trump and its implications.
Explore how tariffs and pricing policies could impact pharma pricing, access, and distribution.
Join our free monthly educational series on market access.
A case study on how RWE was used to calculate the national incidence of a rare disease.
Analysis of the new MFN policy signed by President Trump and its implications.